UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00.

Charles R. Goulding and Preeti Sulibhavi examine how Stryker's acquisition of Inari Medical is set to transform vascular care ...

Stryker (SYK) announced that it commenced, through a wholly owned subsidiary, Eagle 1 Merger Sub Inc., a cash tender offer to ...

PORTAGE, Mich. - Stryker Corporation (NYSE: NYSE:SYK), a global leader in medical technologies, has initiated a cash tender offer through its subsidiary, Eagle 1 Merger Sub, Inc., to acquire all ...

Stryker (SYK) announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, a cash tender offer to purchase all of ...

Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purchase all of the issued and outstanding shares of ...

Jim Cramer, the host of Mad Money, recently highlighted a surge in merger activity, pointing out that we’ve seen a ...

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by ...

Irvine-based Inari Medical Inc. will be acquired by Stryker Corp. for $4.8 billion. The boards of directors of both companies ...

We recently published a list of 10 Firms Post Strong Gains Amid Wall Street Bloodbath. In this article, we are going to take ...

Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for investors. Learn more on SYK stock here.

The suspect in the shooting death of CEO Brian Thompson has garnered sympathy and financial support as he awaits trial, a sign that public support could sway the jury, legal analysts contend. More ...